Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
cisatracurium besilate, Quantity: 2.68 mg/mL (Equivalent: cisatracurium, Qty 2 mg/mL)
Southern Cross Pharma Pty Ltd
cisatracurium besilate
Injection, solution
Excipient Ingredients: benzenesulfonic acid; water for injections
Intravenous
5 vials in a pack
(S4) Prescription Only Medicine
During surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. An adjunct to general anaesthesia, or sedation in intensive care units
Visual Identification: Colourless to pale yellow or yellowish-greenish solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2013-05-29